Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata Guilherme Muzy

Doppler ultrasound protocol for patients with hidradenitis suppurativa Ariany Tomaz de Aquino Saran Denofre, Carolina Meloni Stecca, Juliana Yumi Massuda Serrano, Thais Helena Buffo, Rachel Polo Dertkigil, Renata Ferreira Magalhães

Mid-term effectiveness, safety, and potential predictors of response of upadacitinib in patients with moderate-to-severe atopic dermatitis: a multicenter observational retrospective study Francisco Javier Melgosa Ramos, Carlos Abril Pérez, Santiago Guillén Climent, María Matellanes Palacios, Juncal Roca Ginés, Javier Sabater Abad, Eduardo Bernia Petit, Andrés Casanova Esquembre, Andrea Estébanez Corrales, Victor González Delgado